An angel group based in the Midwest invests up to $200K per company in early stage opportunities. The group usually invests in 9-12 companies per year and participates in convertible rounds, as well as equity investments. The Group is not restricted to Midwest companies, as it will also consider companies throughout the U.S. As membership grows, the group expects the average investment number to increase.
The group is open to all types of life science technology including Therapeutics, Healthcare IT, medical devices, and platform technologies. The group is also indication agnostic. In medical devices, the group is only interested in those in the 510K approval pathway. In terms of stage of development, the group is interested in pre-clinical to Phase I technologies.
The group is interested in companies seeking between $500K to $3M. The group does not have management team requirements though has preference towards those with experience in the space.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 
Leave a comment